PubHawk
June 2024 PMID 38733212

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.

Scott D Solomon, John W Ostrominski, Muthiah Vaduganathan, Brian Claggett, Pardeep S Jhund, Akshay S Desai, Carolyn S P Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Imran Zainal Abidin, Marco Antonio Alcocer-Gamba, John J Atherton

Download social card

Mentions

106
Peak: 55 in Aug 2024
across 2 sources since May 2024

Extended reach

494,021
potential audience

Total likes

482

Video views

11,961

Mentions per month

May 2024 – Aug 2024

Where it's discussed

  • X / Twitter104 posts
  • YouTube2 videos

AI synopsis

What people are saying

Many users express their thoughts on the FINEARTS-HF trial, referencing its enrollment of high-risk patients and potential implications for treatment. Phrases like 'greatly impaired health status' and excited mentions of upcoming results indicate a strong interest in the subject matter, with the tone reflecting a sense of urgency and relevance, as they discuss the potential benefits of finerenone for patient outcomes.

AgreementModerate agreement

Many discussions show general positivity towards the findings, indicating a moderate level of support for the publication's conclusions.

InterestHigh interest

There is significant curiosity expressed about the findings, with users eagerly awaiting more detailed results.

EngagementModerate engagement

While some posts show engagement with the basic concepts, not all deeply analyze the methodologies or implications.

ImpactHigh impact

Several discussions highlight the importance of finerenone in treating heart failure, suggesting a belief that the findings could significantly affect clinical practice.

Abstract in brief

  • The FINEARTS-HF trial aims to evaluate the effects of finerenone, a non-steroidal mineralocorticoid receptor antagonist, on reducing cardiovascular deaths and worsening heart failure events in patients with heart failure (HF) who have mildly reduced or preserved ejection fraction.
  • A total of 6001 patients were randomized, mostly older adults with a mean age of 72 years, a significant proportion of whom had symptoms of heart failure and were at high risk due to recent hospitalizations and functional limitations.
  • The trial seeks to establish the safety and efficacy of finerenone in a diverse, high-risk cohort that may differ from participants in previous heart failure studies, particularly with regard to their
Read the full abstract

Top posts

Most liked on X and Bluesky
Muthu Vaduganathan
@mvaduganathan · X

Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabolites) & ⬇️ hyperK vs spiro Will finerenone safely improve outcomes in HF #FINEARTSHF?

Jun 27, 2024 · 165 likes · 44 shares · 9,158 followers View post →
Almudena Castro Conde
@almucastro01 · X

Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️+ IC

Aug 14, 2024 · 47 likes · 19 shares · 16,035 followers View post →
GoggleDocs
@GoggleDocs · X

FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primary outcome in this pivotal

Aug 22, 2024 · 33 likes · 16 shares · 3,602 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial ESC 2024 1 September HOT LINE LONDON FINEARTS-HF has enrolled a broad range of high-risk patients with HFmrEF and HFpEF https://t.co/vmxu4zRSUK https://t.co/NtxmjtUfDM

Aug 8, 2024 · 22 likes · 9 shares · 2,653 followers View post →
Mehmet Birhan YILMAZ
@cardioceptor · X

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial - Solomon - European Journal of Heart Failure - Wiley Online Library https://t.co/6Y26gKn97f Just published!!! #HeartFailure2024 @mvaduganathan

May 11, 2024 · 10 likes · 2 shares · 2,266 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

#FINEARTSHF Baseline Characteristics Published in #EJHF ✅ Greatly impaired health status (KCCQ-TSS 67) ✅ >50% enrolled within 90d of

Jun 24, 2024 · 5 likes · 9,158 followers View post →

All mentions

Florian Custodis
@floriancustodis · X

RT @gunnar_heine: Heute bei MARKUS at HOMe: Professor Daniel Sedding und @jochen_dutzmann Intervallfasten nach STEMI: INTERFAST-MI https://…

Aug 30, 2024 · 1 share · 750 followers View post →
Gunnar Henrik Heine
@gunnar_heine · X

Heute bei MARKUS at HOMe: Professor Daniel Sedding und @jochen_dutzmann Intervallfasten nach STEMI: INTERFAST-MI https://t.co/QF3lpakvji via @YouTube mit @HaraldSou @StephanSchirme2 @floriancustodis Insa Emrich @dgfn_ev @oegnephro @com_SFNDT

Aug 30, 2024 · 3 likes · 1 share · 2,336 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @Dr_Manito: https://t.co/kiomgpR3UL https://t.co/tlp90liXSQ

Aug 28, 2024 · 2 shares · 9,158 followers View post →
Societat Catalana de Cardiologia
@catcardio · X

RT @Dr_Manito: https://t.co/kiomgpR3UL https://t.co/tlp90liXSQ

Aug 28, 2024 · 2 shares · 4,107 followers View post →
Nicolas Manito
@Dr_Manito · X

https://t.co/kiomgpR3UL https://t.co/tlp90liXSQ

Aug 28, 2024 · 5 likes · 2 shares · 5,469 followers View post →
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X

#ESC24 #FineArtsHF The baseline characteristics have been described here: https://t.co/OnOahuygvH https://t.co/u4NePXKUAN

Aug 27, 2024 · 1 like · 9,801 followers View post →
Harriette Van Spall, MD MPH
@hvanspall · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 17,761 followers View post →
Prof Derek Connolly
@DrDerekConnolly · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 3,919 followers View post →
Lipid Addict
@lipid_pharm · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 3 followers View post →
Nicolas Manito
@Dr_Manito · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 5,474 followers View post →
Arzu Kalayci MD MMSc
@KalayciArzu · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 739 followers View post →
Shelley Zieroth
@ShelleyZieroth · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 9,989 followers View post →
GoggleDocs
@GoggleDocs · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 3,602 followers View post →
Laura Cox
@LauraCoxD · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 94 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 9,083 followers View post →
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 9,790 followers View post →
Dr Rani Khatib FESC
@DrRaniKhatib · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 5,429 followers View post →
SultanSBAlSA
@SultanSBAlSA · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 45 followers View post →
Amrit
@dr_amritlamba · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 356 followers View post →
James Ridgeway
@James_Ridgeway_ · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 2,840 followers View post →
Dr Anastasia Mihailidou FAHA FCSANZ FESC
@AnastasiaSMihai · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 19,249 followers View post →
Patrick Holmes
@drpatrickholmes · X

RT @GoggleDocs: FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primar…

Aug 22, 2024 · 16 shares · 3,347 followers View post →
GoggleDocs
@GoggleDocs · X

FINEARTS-HF =“fine ❤️s”❓ Full results on Sunday @escardio #ESCCongress However we have top line that Finenerone ⤵️ primary outcome in this pivotal

Aug 22, 2024 · 33 likes · 16 shares · 3,602 followers View post →
unimusashi（N. Ashikawa）
@uni_pharmacist · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 17, 2024 · 9 shares · 1,333 followers View post →
Hiroyuki Sato 佐藤宏行
@foreverhero0819 · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 16, 2024 · 9 shares · 3,786 followers View post →
Alejandro Gutiérrez
@AGutierrezFdez · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 16, 2024 · 19 shares · 218 followers View post →
Roberto Arcadio
@Robertoarcadio_ · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 305 followers View post →
Raul Villar
@DrRaulvillar · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 410 followers View post →
Miguel Turégano
@tureyedro · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 812 followers View post →
David
@DavidLL95 · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 364 followers View post →
Finerenona España
@KerendiaEsp · X

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial https://t.co/K3b2cPLfME https://t.co/yKnSAdCuKH

Aug 15, 2024 · 1 like · 233 followers View post →
Dani Salas
@pollitodeanaga · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 412 followers View post →
@Heart_Team
@Heart_Team1 · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 449 followers View post →
Carmealonso3
@Carmealonso31 · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 128 followers View post →
Jose Luis Górriz
@jlgorriz · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 8,597 followers View post →
Jaime Larre Guerra
@jalarreg97 · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 91 followers View post →
IARETUSA
@IARETUSA · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 1,805 followers View post →
Alberto Cordero
@acorderofort · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 4,894 followers View post →
Manuel Gaxiola
@cardiogax · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 15, 2024 · 19 shares · 7,985 followers View post →
Nelson murillo
@nemurillob · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 14, 2024 · 19 shares · 247 followers View post →
Sergio Ríos Sibaja
@SergioRosSibaj1 · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 14, 2024 · 19 shares · 29 followers View post →
Guillermina Esperon
@Guilleresperon · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 14, 2024 · 19 shares · 2,049 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 14, 2024 · 19 shares · 999 followers View post →
Ros
@RosembergP33633 · X

RT @almucastro01: Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️…

Aug 14, 2024 · 19 shares · 32 followers View post →
Almudena Castro Conde
@almucastro01 · X

Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️+ IC

Aug 14, 2024 · 47 likes · 19 shares · 16,035 followers View post →
Umar Shakur
@u_shakur · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 12, 2024 · 9 shares · 294 followers View post →
juan ramon
@RamonTasmania · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 8, 2024 · 9 shares · 94 followers View post →
Manuel Gaxiola
@cardiogax · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 8, 2024 · 9 shares · 7,985 followers View post →
Graham Abra, MD
@GrahamAbra · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 8, 2024 · 9 shares · 2,662 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 8, 2024 · 9 shares · 9,158 followers View post →
Umut Kocabaş
@UmutKocabasMD · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Aug 8, 2024 · 9 shares · 1,458 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial ESC 2024 1 September HOT LINE LONDON FINEARTS-HF has enrolled a broad range of high-risk patients with HFmrEF and HFpEF https://t.co/vmxu4zRSUK https://t.co/NtxmjtUfDM

Aug 8, 2024 · 22 likes · 9 shares · 2,653 followers View post →
Emmanuel Scatularo MD
@EmmanuelScatu · X

https://t.co/cqBLGllcUe

Aug 6, 2024 · 2 likes · 2,332 followers View post →
Lorenzo Fácila
@mi_cardiologo · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jul 16, 2024 · 44 shares · 7,942 followers View post →
Cole Smith, Pharm.D, BCPS
@iamcrsmith · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 29, 2024 · 44 shares · 690 followers View post →
Charles Fauvel
@CharlesFauvel · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 29, 2024 · 44 shares · 1,505 followers View post →
Antonio Antonucci
@pasquiz_85 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 29, 2024 · 44 shares · 218 followers View post →
Dr. Christian Velasquez
@drchvelasquezb · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 29, 2024 · 44 shares · 109 followers View post →
Hyeok-Hee Lee
@HHLeeMD · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 263 followers View post →
Brayan Rizo
@RizoBrayan · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 314 followers View post →
Mehmet Birhan YILMAZ
@cardioceptor · X

RT @drbennisahmed: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS…

Jun 28, 2024 · 2 shares · 2,266 followers View post →
Dr. Osmar Perez S.
@osmarperse · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 2,457 followers View post →
Carito Zumaeta
@carilisszc1 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 67 followers View post →
Bassam Atallah, PharmD
@batallah08 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 480 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial FINEARTS-HF has enrolled a broad range of high-risk patients with HFmrEF and HFpEF https://t.co/X51183dywE https://t.co/HnQEcEZ8du

Jun 28, 2024 · 5 likes · 2 shares · 2,653 followers View post →
Matthew Harris
@mattdh86 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 386 followers View post →
Christian Ntizimira
@ntizimira · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 3,647 followers View post →
Kingston
@kianboy · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 462 followers View post →
Jamie Willows
@jamiekwillows · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 3,144 followers View post →
@MARTINSVEL
@MARTINSVEL · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 28, 2024 · 44 shares · 413 followers View post →
sejal kotwani
@KotwaniSejal · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 424 followers View post →
Jamie Wang
@jamiewang1228 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 9 followers View post →
orion77
@orion7710 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 1,482 followers View post →
Faby G.
@Fabiolaghh · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 410 followers View post →
rafavidalperez
@rafavidalperez · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 13,838 followers View post →
Edouard L. Fu
@FuEdouard · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 1,050 followers View post →
Dr. Martha Gulati ♥️
@DrMarthaGulati · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 64,745 followers View post →
Julia Seller
@JuliaSellerm · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 6,013 followers View post →
Umut Kocabaş
@UmutKocabasMD · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 1,458 followers View post →
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 9,801 followers View post →
Prof Chris P Gale
@cpgale3 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 13,469 followers View post →
| Daniel Sierra LM |
@DanielSierraLM · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 2,499 followers View post →
د . احمد سمان
@Ahmed43101178 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 6,358 followers View post →
Shelley Zieroth
@ShelleyZieroth · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 9,994 followers View post →
Umaira Aziz
@documi · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 1,040 followers View post →
Rhys Williams
@RhysWMPharm · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 1,197 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 32,515 followers View post →
Abdallah Al-Mohammad
@AAlMohammad87 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 926 followers View post →
Yevgeniy Brailovsky DO MSc FACC
@YevgeniyBr · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 2,961 followers View post →
Maggie Simpson
@m4ggiesimpson · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 4,389 followers View post →
Manuel Méndez
@mendez_bailon · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 7,783 followers View post →
Dr.Vaibhav Triapthi MD
@DrVaibhav1992 · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 191 followers View post →
Ryan J Tedford MD
@RyanTedfordMD · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 9,674 followers View post →
Cornerstone Medical Education
@Cornerstone_CME · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 144 followers View post →
Sarah Melville
@sarahkmels · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 2,173 followers View post →
Dr. Sou
@SwissHeartDoc · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 883 followers View post →
MedEd Global Solutions
@global_meded · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 243 followers View post →
Andrew J Sauer MD
@AndrewJSauer · X

RT @mvaduganathan: Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabol…

Jun 27, 2024 · 44 shares · 19,279 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

Finerenone has a cleaner pharmacological profile (selective, short half-life, balanced heart/kidney, & no active metabolites) & ⬇️ hyperK vs spiro Will finerenone safely improve outcomes in HF #FINEARTSHF?

Jun 27, 2024 · 165 likes · 44 shares · 9,158 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

#FINEARTSHF Baseline Characteristics Published in #EJHF ✅ Greatly impaired health status (KCCQ-TSS 67) ✅ >50% enrolled within 90d of

Jun 24, 2024 · 5 likes · 9,158 followers View post →
宇津 貴史 /Utsu, Takashi
@Office_j · X

【追記】 １日おいて今度はベースラインデータ論文。 https://t.co/SLbIpLU3bV https://t.co/gjwwIHEhHL

May 16, 2024 · 1 like · 1 share · 4,902 followers View post →
juan ramon
@RamonTasmania · X

RT @cardioceptor: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐…

May 11, 2024 · 2 shares · 94 followers View post →
Maggie Simpson
@m4ggiesimpson · X

RT @cardioceptor: Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐…

May 11, 2024 · 2 shares · 4,389 followers View post →
Mehmet Birhan YILMAZ
@cardioceptor · X

Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial - Solomon - European Journal of Heart Failure - Wiley Online Library https://t.co/6Y26gKn97f Just published!!! #HeartFailure2024 @mvaduganathan

May 11, 2024 · 10 likes · 2 shares · 2,266 followers View post →